Turkey: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Turkey

In 2022, the Turkish prophylactic medicaments containing insulin market decreased by -0.1% to $X, falling for the second consecutive year after five years of growth. In general, the total consumption indicated a strong expansion from 2012 to 2022: its value increased at an average annual rate of +6.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -0.8% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Turkey

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Overall, the total production indicated a resilient increase from 2012 to 2022: its value increased at an average annual rate of +6.2% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -0.4% against 2020 indices. The pace of growth was the most pronounced in 2014 with an increase of 23% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Turkey

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by 210% to X tons, rising for the third year in a row after two years of decline. Over the period under review, exports enjoyed significant growth. The growth pace was the most rapid in 2021 when exports increased by 1,608% against the previous year. Over the period under review, the exports attained the peak figure in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. In general, exports enjoyed significant growth. The most prominent rate of growth was recorded in 2021 when exports increased by 1,274% against the previous year. The exports peaked in 2022 and are expected to retain growth in the immediate term.

Exports by Country

Iran (X tons) was the main destination for prophylactic medicaments containing insulin exports from Turkey, with a approx. 99% share of total exports.

From 2012 to 2022, the average annual growth rate of volume to Iran stood at +1,832.7%.

In value terms, Iran ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Turkey.

From 2012 to 2022, the average annual growth rate of value to Iran amounted to +1,163.4%.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, which is down by -19.2% against the previous year. Over the period under review, the export price saw a drastic downturn. The pace of growth appeared the most rapid in 2019 when the average export price increased by 142%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Iran.

From 2012 to 2022, the rate of growth in terms of prices for North Macedonia amounted to +88.9% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Turkey

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -18.3% to X tons for the first time since 2018, thus ending a three-year rising trend. Overall, total imports indicated a remarkable increase from 2012 to 2022: its volume increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2013 when imports increased by 25%. Over the period under review, imports hit record highs at X tons in 2021, and then reduced sharply in the following year.

In value terms, prophylactic medicaments containing insulin imports declined to $X in 2022. The total import value increased at an average annual rate of +1.2% over the period from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations throughout the analyzed period. The most prominent rate of growth was recorded in 2013 with an increase of 18%. Over the period under review, imports attained the peak figure at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

Brazil (X tons), Germany (X tons) and Italy (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Turkey, with a combined 93% share of total imports. France, China and Denmark lagged somewhat behind, together accounting for a further 7.1%.

From 2012 to 2022, the biggest increases were recorded for China (with a CAGR of +1,516.6%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Brazil ($X), Germany ($X) and China ($X) were the largest prophylactic medicaments containing insulin suppliers to Turkey, together accounting for 85% of total imports.

In terms of the main suppliers, China, with a CAGR of +1,381.6%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, with an increase of 12% against the previous year. In general, the import price, however, continues to indicate a perceptible decline. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was China ($X per ton), while the price for Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (+16.3%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :